India, Sept. 4 -- Two formulations of the vaccine have been developed: One could be introduced through global supply chain and other in hard-to-reach regions

A study funded by the Ministry of Health of the Russian Federation has made public that their vaccine Sputnik V does not have any adverse effects and is effective in eliciting immune response. The findings of the first two phases of clinical trials were published in The Lancet on September 4, 2020.

The vaccine has to be taken in two doses - the initial and booster dose. Both doses use adenovirus (cold virus and generally considered safe) as the vector to ferry the novel coronavirus SARS-CoV-2 spike protein genetic code to the human body. These proteins teach the immune system of a ...